W Symonds
Overview
Explore the profile of W Symonds including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
100
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drusano G, DArgenio D, Preston S, Barone C, Symonds W, Lafon S, et al.
Antimicrob Agents Chemother
. 2000 May;
44(6):1655-9.
PMID: 10817724
The delineation of optimal regimens for combinations of agents is a difficult problem, in part because, to address it, one needs to (i) have effect relationships between the pathogen in...
2.
Deeks S, Hellmann N, Grant R, Parkin N, Petropoulos C, Becker M, et al.
J Infect Dis
. 1999 May;
179(6):1375-81.
PMID: 10228057
Twenty human immunodeficiency virus-infected patients experiencing virologic failure of an indinavir- or ritonavir-containing treatment regimen were evaluated in a prospective, open-label study. Subjects received nelfinavir, saquinavir, abacavir, and either another...
3.
Hughes W, McDowell J, Shenep J, Flynn P, Kline M, Yogev R, et al.
Antimicrob Agents Chemother
. 1999 Feb;
43(3):609-15.
PMID: 10049275
Abacavir (formerly 1592U89) is a potent 2'-deoxyguanosine analog reverse transcriptase inhibitor that has been demonstrated to have a favorable safety profile in initial clinical trials with adults with human immunodeficiency...
4.
Kumar P, Sweet D, McDowell J, Symonds W, Lou Y, Hetherington S, et al.
Antimicrob Agents Chemother
. 1999 Feb;
43(3):603-8.
PMID: 10049274
Abacavir (1592U89) is a nucleoside analog reverse transcriptase inhibitor that has been demonstrated to have selective activity against human immunodeficiency virus (HIV) in vitro and favorable safety profiles in mice...
5.
Drusano G, DArgenio D, Symonds W, Bilello P, McDowell J, Sadler B, et al.
Antimicrob Agents Chemother
. 1998 Sep;
42(9):2153-9.
PMID: 9736527
The use of combinations of anti-human immunodeficiency virus (anti-HIV) agents targeted to different molecular targets will most likely result in increased viral suppression and may also delay or prevent the...